Showing results (81-90 of 1,457) with videos related to

Sort By:
Pageof 146
Genome Research|January 19, 2023
An efficient genotyper and star-allele caller for pharmacogenomicsAnanth Hari, Qinghui Zhou, Nina Gonzaludo, et al.
Computational Intelligence and Neuroscience|June 20, 2022
Nomogram to Predict Overall and Cancer-Specific Survival in Patients with Synovial Sarcoma in the Extremities: A Population-Based StudyXing-Yao Yang, Xin He, Yun Zhao
Zhongguo Gu Shang = China Journal of Orthopaedics and Traumatology|March 22, 2024
[Influencing factors of traumatic arthritis after ankle fracture surgery and construction of risk prediction model]Song Li, Cheng-Yao Yang, Qian Peng
BMC Pulmonary Medicine|June 24, 2022
Prognostic factors for advanced lung cancer patients with do-not-intubate order in intensive care unit: a retrospective studyChia-I Shen, Shan-Yao Yang, Hwa-Yen Chiu, et al.
Circulation. Cardiovascular Interventions|October 6, 2011
CYP2C19 but not PON1 genetic variants influence clopidogrel pharmacokinetics, pharmacodynamics, and clinical efficacy in post-myocardial infarction patientsJean-Sébastien Hulot, Jean-Philippe Collet, Guillaume Cayla, et al.
Current Opinion in Biotechnology|April 20, 2010
Biodiesel from algae: challenges and prospectsStuart A Scott, Matthew P Davey, John S Dennis, et al.
American Journal of Medical Genetics. Part A|March 6, 2020
Haploinsufficiency of the basic helix-loop-helix transcription factor HAND2 causes congenital heart defectsAna S A Cohen, Christopher Simotas, Bryn D Webb, et al.
Human Mutation|July 2, 2019
Structural variation at the CYP2C locus: Characterization of deletion and duplication allelesMariana R Botton, Xingwu Lu, Geping Zhao, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 8, 2012
Laboratory testing of CYP2D6 alleles in relation to tamoxifen therapyElaine Lyon, Julie Gastier Foster, Glenn E Palomaki, et al.
Leukemia Research|July 27, 2005
5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylationStuart A Scott, Wei-Feng Dong, Ryo Ichinohasama, et al.
Pageof 146